Steven J. Swanson serves as Executive at ImmunoCellular Therapeutics, Ltd., where they oversee executive responsibilities. Since joining the company, Steven J. Swanson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 11, 2016 involved receiving (via award) 25,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 11, 2016 | IMUC | $0 | Award | 25,000 | $N/A | Discretionary |
Steven J. Swanson currently holds 25,000 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven J. Swanson has been a net neutral trader of IMUC stock. They have purchased $0 and sold $0 worth of shares.
Steven J. Swanson's most recent insider trade was on Mar 11, 2016, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted